Answers are grounded in this paper and cite their sources.
Shows increased heart failure risk in breast cancer and lymphoma patients treated with anthracyclines compared to controls, highlighting the need to monitor long-term chemotherapy side effects.
Patients with a diagnosis of breast cancer or lymphoma who received chemotherapy treatment might be at risk of long-term side effects. We evaluated the association between a type of chemotherapy, called anthracyclines, and the risk of developing heart failure in patients with cancer. In this study, patients treated with anthracycline were more likely to have heart failure compared to controls.
No takes yet. Share an insight, caveat, or question.
Villarraga et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: